- $44.61bn
- $58.66bn
- $16.31bn
IQVIA backs AI strategy as analysts question impact on business (updated)
IQVIA falls after forecasting annual profit below estimates
IQVIA forecasts weak annual profit on higher interest expenses
IQVIA Q4 revenue rises 10.3%, beats analyst estimates
Brief: IQVIA Q4 Adjusted EPS USD 3.42 Vs. IBES Estimate USD 3.4
U.S. RESEARCH ROUNDUP-Autonation, Eastman Chemical, Fortive
Factbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines
Life sciences and contract research stocks navigate turbulence in 2025
Brief: Iqvia Announces Strategic Collaboration With AWS, Naming AWS As Preferred Agentic Cloud Provider To Power Next-Generation AI Platform
U.S. RESEARCH ROUNDUP-Green Brick Partners, Pultegroup, Toll Brothers
U.S. RESEARCH ROUNDUP-Bankunited, Chevron, Paychex
Brief: Dr. William G. Kaelin Jr. Joins Iqvia Board Of Directors
Preview: In Lilly vs Novo obesity drug battle, Trump price talks grab focus
U.S. RESEARCH ROUNDUP-ATI, GoDaddy, Lyft
IQVIA narrows annual profit forecast amid continued research contract cancellations (updated)
IQVIA narrows annual profit forecast amid continued research contract cancellations
Healthcare analytics firm IQVIA beats Q3 revenue estimates, reaffirms guidance
Newscasts - War on drug prices
Newscasts - Slashing US drug prices would come at a cost